We have located links that may give you full text access.
Enrichment of lung microbiome with supraglotic microbes is associated with increased pulmonary inflammation.
Annals of the American Thoracic Society 2014 January
Oral flora are frequently found in normal individuals' lungs without known harm. We hypothesize that a lung microbiome enriched by oral taxa would be associated with a higher degree of inflammation. We studied 29 asymptomatic subjects (9 nonsmokers and 20 smokers) with preserved lung function. Nasal bronchoscopy was performed with two separate bronchoscopes to retrieve supraglotic and lower airway samples. Bronchoalveolar lavage (BAL) cell count, BAL cytokines (Luminex), and exhaled nitric oxide defined pulmonary inflammation. Quantitative PCR measured 16S rRNA gene concentration and 454 sequences defined the microbiome. Supraglotic samples had the highest 16S rRNA concentration, BAL was intermediate, and saline used for the BAL had the lowest concentration. Nonsmokers and smokers were similar in BAL cell differential and lung microbiome. BAL samples segregated into two distinct groups that we called pneumotypes. Pneumotype background predominant taxa (pneumotypeBPT) was similar to the saline background in rDNA concentration or microbial community. Pneumotype supraglotic-characteristic taxa (pneumotypeSCT) has higher rDNA concentration and high relative abundance of SCT, such as Prevotella and Veillonella. PneumotypeSCT was associated with multiple measures of lung inflammation, including higher BAL neutrophils, IL-8, and levels of exhaled nitric oxide. PneumotypeSCT also had higher BAL lymphocytes and fractalkine, a chemokine that correlates with T helper type 17:T regulatory cell ratio in the BAL. These data suggest that a pneumotype with high relative abundance of supraglotic bacteria, such as Prevotella and Veillonella, is associated with increased innate and cellular inflammation.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app